Atea Pharmaceuticals (NasdaqGS:AVIR) FY Conference Transcript

Atea Pharmaceuticals (NasdaqGS:AVIR) FY Conference December 03, 2025 10:00 AM ET Company ParticipantsJohn Vavricka - Chief Commercial OfficerJean-Pierre Sommadossi - Founder, Chairman, and CEOArantxa Horga - Chief Medical OfficerOperatorAll right. Welcome, everybody, to Atea this morning. We've got JP, we've got the whole team, but we've got JP starting us off with a brief presentation on some recent announcements.Jean-Pierre SommadossiOkay, great. Thank you, John. Really appreciate the opportunity today. J ...